Skip to main content
. 2019 Oct 9;7(10):e14408. doi: 10.2196/14408

Table 2.

Comparison of exacerbation-related outcomes between intervention group and control group (N=85).

Outcome Mobile health tool intervention group (n=41), mean (SD) Paper action plan control group (n=44), mean (SD) Rate ratio (95% CI)a P value
Exacerbation-free weeksb 30.6 (13.3) 28.0 (14.8) 1.21 (0.77-1.90) .40
Unscheduled health care consultations because of respiratory complaintsc 1.6 (1.7) 1.6 (2.0) 0.89 (0.50-1.60) .70
Symptom-based exacerbationsb 4.5 (2.3) 4.3 (2.1) 1.07 (0.65-1.75) .80
Exacerbations treated with antibiotics and/or prednisolonec 1.1 (1.5) 1.0 (1.3) 1.01 (0.53-1.93) .97
Exacerbation-related hospital admissionsc 0.15 (0.43) 0.14 (0.41) 1.25 (0.35-4.44) .74

aCalculated using negative binomial regression analyses, relative to participants’ follow-up time, controlling for age and gender.

bData retrieved from weekly patient reports.

cData retrieved from patient medical files.